ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Improving the SIENA performance using BEaST brain extraction

Nakamura, Kunio*; Eskildsen, Simon F.; Narayanan, Sridar; Arnold, Douglas L.; Collins, D. Louis
PLoS One2018-9-20DOI: 10.1371/journal.pone.0196945
7被引1阅读
引用收藏
分享

摘要

We present an improved image analysis pipeline to detect the percent brain volume change (PBVC) using SIENA (Structural Image Evaluation, using Normalization, of Atrophy) in populations with Alzheimer's dementia. Our proposed approach uses the improved brain extraction mask from BEaST (Brain Extraction based on nonlocal Segmentation Technique) instead of the conventional BET (Brain Extraction Tool) for SIENA. We compared four varying options of BET as well as BEaST and applied these five methods to analyze scan-rescan MRIs in ADNI from 332 subjects, longitudinal ADNI MRIs from the same 332 subjects, their repeat scans over time, and OASIS longitudinal MRIs from 123 subjects. The results showed that BEaST brain masks were consistent in scan-rescan reproducibility. The cross-sectional scan-rescan error in the absolute percent brain volume difference measured by SIENA was smallest (p <= 0.0187) with the proposed BEaST-SIENA. We evaluated the statistical power in terms of effect size, and the best performance was achieved with BEaST-SIENA (1.2789 for ADNI and 1.095 for OASIS). The absolute difference in PBVC between scan-dataset (volume change from baseline to year-1) and rescan-dataset (volume change from baseline repeat scan to year-1 repeat scan) was also the smallest with BEaST-SIENA compared to the BET-based SIENA and had the highest correlation when compared to the BET-based SIENA variants. In conclusion, our study shows that BEaST was robust in terms of reproducibility and consistency and that SIENA's reproducibility and statistical power are improved in multiple datasets when used in combination with BEaST.

学科与关键词

关键词
MULTIPLE-SCLEROSISALZHEIMERS-DISEASEMRI DATAATROPHYREGISTRATIONPROGRESSIONIMAGESROBUSTADNIFSL
相关
加载中…
  • Enhanced brain extraction improves the accuracy of brain atrophy estimation
    Battaglini, Marco; Smith, Stephen M.; Brogi, Susanna; De Stefano, Nicola*NeuroImage, 2008, 40(2): 583-589.被引 61
  • SIENA-XL for Improving the Assessment of Gray and White Matter Volume Changes on Brain MRI
    Battaglini, Marco*; Jenkinson, Mark; De Stefano, NicolaHUMAN BRAIN MAPPING, 2018, 39(3): 1063-1077.被引 21
  • Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model
    Dwyer, Michael G.*; Bergsland, Niels; Zivadinov, RobertNeuroImage, 2014, 90: 207-217.被引 50
查看全部 →

发表信息

论文状态
公开发表
期刊
PLoS One
发表日期
2018-09-20
卷期
第 13 卷, 第 9 期
页码
e0196945
DOI
10.1371/journal.pone.0196945
语言
ENGLISH
期刊等级
Q1
成果收录
SCIE
资助标注
Mitacs ELEVATE Fellowship [IT03292]; Neuroinflammation Training Program; Canada Foundation for Innovation (CFI); NanoQuebec; RMGA; Fonds de recherche du Quebec - Nature et technologies (FRQ-NT); FRSQ-Pfizer Innovation grant; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense award) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Mes Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceutical Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transitio Therapeutics; Canadian Institutes of Health Research; Northern California Institute for Research and Education; Sanofi Genzyme; National Institutes of Health; Department of Defense; Danish Research Council for Independent Research [DFF-4004-00305]; Novartis

作者

  • N

    Nakamura, Kunio (通讯) (第一作者)

  • E

    Eskildsen, Simon F.

查看全部 5 位作者收起作者
  • N

    Narayanan, Sridar

  • A

    Arnold, Douglas L.

  • C

    Collins, D. Louis

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417